Showing results (191-200 of 264) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911Theodorus H Van der Kwast, Michel Bolla, Hein Van Poppel, et al.European Journal of Cancer (Oxford, England : 1990)|July 14, 2007
Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921Marcel den Dulk, Laurence Collette, Cornelis J H van de Velde, et al.Journal of Cancer Policy|December 21, 2025
INNOVATIVE ONCOLOGY TRIAL DESIGNS: TIME TO ACT A review with recommendations of the Cancer Drug Development ForumRosa Giuliani, Nafsika Kronidou-Horst, Christina Yap, et al.European Urology Open Science|September 15, 2023
Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in NonseminomaChristian D Fankhauser, Abolghassem Jandari, Laurence Collette, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983Ronald de Wit, Iwona Skoneczna, Gedske Daugaard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer GroupsBerend J Slotman, Murielle E Mauer, Andrew Bottomley, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863Fatma Ataman, Alfredo Zurlo, Xavier Artignan, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2006
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882Ninja Antonini, Heather Jones, Jean Claude Horiot, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 23, 2020
Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trialsMaria Antonietta Gambacorta, Carlotta Masciocchi, Giuditta Chiloiro, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2008
Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trialPhilip M Poortmans, Laurence Collette, Jean-Claude Horiot, et al.Pageof 27